Danaher Corporation
Price data unavailable
Track DHR in your trading journalAbout Danaher Corporation
Danaher Corporation (Nasdaq/NYSE: DHR) is a Life Sciences Tools & Services company operating within the Health Care sector of the US equity market.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
The company reports trailing twelve-month revenue of $5.36B and net income of $1.03B.
Key metrics include a return on equity of 1.9%, a debt-to-equity ratio of 0.16.
Use FINOTAUR to track DHR's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $5.36B |
| Net Income (TTM) | $1.03B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 1.94% |
| Debt-to-Equity | 0.16 |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 21
Tissue Diagnostics Market to Reach USD 9.33 Bn by 2031 Driven by Expanding Precision Oncology Applications and Rising Adoption of Digital Pathology, Says Mordor Intelligence
- GlobeNewswire Inc.·May 14
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight
- Benzinga·May 12
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
Want real-time analysis on DHR?
Track it free in your trading journal. Log trades, tag setups, and review your edge.